Facilities Featured Articles
-
A Strategic Approach To Purchasing And Integrating Solid Dose Equipment
5/24/2017
Acquiring pharmaceutical processing equipment and successfully integrating it into operations is not as straightforward as it may seem.
-
Perfect Potent API Processing: Handling Hazardous Drug Actives Effectively
10/25/2016
The journey from discovery to pharmacy is long and arduous, particularly for highly potent APIs, which must be handled in compliance with complex regulatory requirements at each stage.
-
Increase The Speed To Clinic Of New Biopharmaceuticals With This Approach
9/14/2016
Biopharma must balance the commercial risks inherent in drug development with their need to control development costs while ensuring final manufacturing processes deliver the lowest cost of goods.
-
Methods Of Containment For Solid Dose Blending And Manufacturing
9/2/2016
Two methods of containing blenders have been demonstrated. Included here are the use of flexible enclosures and separate, disposable powder transfer systems.
-
New Possibilities In Laboratory Automation With Ready-To-Install Subsystems
8/26/2016
Analytical laboratories have to provide sound results in a short time. Speed and reproducibility play a significant role here. Modern automation technology saves time, increases quality and reduces costs.
-
Automating Technology In The Production Of Infusion And Blood Bags
8/26/2016
When manufacturing bags for medical fluids, extreme precision and high production speeds are of the utmost importance.
-
A Wake-Up Call For APAC: FDA Requires Electronic Submissions By 2017
8/17/2016
The demand for generic drugs is skyrocketing. According to the US FDA, nearly 8 in 10 prescriptions filled in the United States are for generic drugs. Generic drugs can be considerably less expensive while typically providing the same level of effectiveness as brand name therapeutics. The demand is intensified by initiatives such as the Affordable Care Act that intend to lower the cost of national healthcare by compelling a move toward less expensive generics and biosimilars.
-
Establishing Best Practice Qualification Metrics For Smart Shipping Containers
6/21/2016
Wernher von Braun, the father of modern rocketry famously stated, “one test is worth a thousand expert opinions.” The FDA has put their own regulatory spin on this axiom: “if you didn’t document it; it didn’t happen.” This extends beyond the drug therapies themselves to the packaging and logistics practices that are used to distribute them; what the FDA refers to as the “holding” of a drug.
-
Automatic Lubrication Systems Enhance Performance And Cut Costs In Pharmaceutical Manufacturing
6/7/2016
The latest in automated lubrication systems ensure optimum equipment performance — even in demanding pharmaceutical manufacturing environments — and reduce unscheduled maintenance.
-
BioMarin Transforms Supplier M&A Into Joint Ventures
4/25/2016
To navigate supplier and CMO consolidation, Isaac Young, senior director, supply chain operations, BioMarin Pharmaceutical Inc., offers some advice: Approach your outsourcing relationships like joint ventures. “As you have this greater engagement between two companies,” says Young, “you’re likely to enter an interdependent relationship. Why not acknowledge that rather than try to power-play or position one another?”